Elevated levels of GLP-1 and GIP or use of their DPP-4-resistant analogues has been shown to provide neurotrophic, neuroprotective, and anti-inflammatory actions in cellular and animal models of PD as well as other age-associated neurodegenerative disorders [6, 13–28]. Here, GLP1R is linked to Parkinson disease.